Diagnostic delays, treatment timeliness, and patient experiences in triple-negative breast cancer: a mixed-methods study
Frontiers in Oncology · 04.08.2026 · 16
DOI: 10.3389/fonc.2026.1826987 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift Frontiers in Oncology, online erschienen am 04.08.2026. Verfasst von Marcela Mazo Canola und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, University of Texas Health San Antonio, San Antonio, TX, United States. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that disproportionately affects younger patients, and Black and Hispanic/Latina patients. Timely diagnosis and treatment initiation are critical for optimal outcomes, yet variation in care delivery and delays in treatment initiation persist. While administrative data have documented differences in treatment timeliness, less is known about how patients experience the early TNBC care pathway and how these experiences relate to observed healthcare utilization patterns.
Methods
We conducted a convergent parallel mixed-methods study integrating qualitative interviews with patients diagnosed with TNBC and a retrospective analysis of administrative claims data. Semi-structured interviews were conducted with 42 patients in the United States, intentionally oversampling Black, Hispanic/Latina, and younger patients. Quantitative analyses examined screening, diagnostic utilization, time to treatment initiation, and post-treatment care utilization among 6,345 commercially insured patients and patients with Medicaid managed care (MMC). Qualitative and quantitative findings were analyzed independently and then integrated to identify areas of convergence, divergence, and expansion.
Results
Quantitative analyses identified observed differences in adjusted time to neoadjuvant treatment initiation among Black and Hispanic/Latina patients enrolled in MMC, with adjusted mean times increasing from 44.2 days (95% CI: 40.7–48.0) among White patients to 63.2 days (95% CI: 58.1–68.8) among Hispanic/Latina patients and 82.1 days (95% CI: 75.3–89.4) among Black patients. Qualitative findings provided context for these observed patterns, with participants describing symptom dismissal, difficulties translating complex clinical information into meaningful understanding, insurance-related barriers, and logistical challenges that may affect escalation and treatment readiness. Divergences highlighted limitations of claims-based measures, including their inability to capture emotional distress, uncertainty, feeling unseen within care interactions, fragmented care experiences, and inadequate preparation for treatment side effects.
Conclusion
By integrating patient experiences with claims-based analyses, this study provides hypothesis-generating insights into early TNBC care pathways and identifies potential inflection points where health system interventions, particularly patient navigation and tailored education, may support more equitable, coordinated, and patient-centered care, across the TNBC care continuum.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology-Oncology, University of Texas Health San Antonio, San Antonio, TX, United States.
- Polaris Global Health Solutions, Austin, TX, United States.
- Avalere Health, Washington, DC, United States.
- Gilead Sciences, Inc., Foster City, CA, United States.
Zitieren
APA
Mazo Canola, M., Schear, R., Housman, L. T., Backus, K. V., & Hogea, C. (2026). Diagnostic delays, treatment timeliness, and patient experiences in triple-negative breast cancer: a mixed-methods study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1826987
Vancouver
Mazo Canola M, Schear R, Housman LT, Backus KV, Hogea C. Diagnostic delays, treatment timeliness, and patient experiences in triple-negative breast cancer: a mixed-methods study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1826987
BibTeX
@article{MazoCanola2026,
author = {Mazo Canola, Marcela and Schear, Rebekkah and Housman, Laura T and Backus, Kandis V and Hogea, Cosmina},
title = {Diagnostic delays, treatment timeliness, and patient experiences in triple-negative breast cancer: a mixed-methods study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1826987}
}
EUVIMED